[go: up one dir, main page]

TWI238852B - A new extraction method and application of antrodia camphorata to reduce the damage from chemotherapy for cancer and enhance the erythropoiesis in bone marrow - Google Patents

A new extraction method and application of antrodia camphorata to reduce the damage from chemotherapy for cancer and enhance the erythropoiesis in bone marrow Download PDF

Info

Publication number
TWI238852B
TWI238852B TW92124881A TW92124881A TWI238852B TW I238852 B TWI238852 B TW I238852B TW 92124881 A TW92124881 A TW 92124881A TW 92124881 A TW92124881 A TW 92124881A TW I238852 B TWI238852 B TW I238852B
Authority
TW
Taiwan
Prior art keywords
antrodia camphorata
bone marrow
water
chemotherapy
extraction method
Prior art date
Application number
TW92124881A
Other languages
Chinese (zh)
Other versions
TW200510523A (en
Inventor
Wei-Ju Yang
Hsien-Tung Yen
Tsung-Chi Tsai
Original Assignee
Uni President Entpr Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uni President Entpr Corp filed Critical Uni President Entpr Corp
Priority to TW92124881A priority Critical patent/TWI238852B/en
Publication of TW200510523A publication Critical patent/TW200510523A/en
Application granted granted Critical
Publication of TWI238852B publication Critical patent/TWI238852B/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

We found a new extraction method and application of Antrodia camphorata in promoting and protecting the Erythropoiesis after the chemotherapy of cyclophosphamide. We extracted the Antrodia camphorata with the following procedure: 3 gram powder dissolved in water with 121 DEG C for 10-30 minutes, then centrifuge to discard the precipitates, add the same volume of 95% ethanol, then shaking for 8 hours, centrifuge again with 4000 rpm for 10 minutes, discard the precipitates, keep the supernatant do the following experiments. In the in vivo experiment, we found the peripheral blood cell number increase from 2.7000 ± 1.0801x10<3>/ul to 4.6250 ± 4.2161x10<3>/ul after the cyclophosphamide injection in the water and Antrodia camphorata treatment, respectively. In the in vitro experiment, we scarified the mice with cyclophosphamide injection after 6 days feeding with Antrodia camphorata, took out of mice bone marrow cells and cultivated to count the colony numbers, the number increase from 23.7500 ± 5.9090 to 42.0000 ± 4.9666 in the positive and negative control, respectively.

Description

12388521238852

【發明所屬之技術領域】 癌症輔助治療、藥用真菌、機能性保健食品等、血球增生。 【先前技術】 樟芝屬於台灣獨有物種,因此在世界其他各國皆未發現有關於樟芝的硏究 報告。在固態子實體栽培方面,國內許多真菌栽培專家曾試圖固態培養樟 芝子實體,皆未成功;目前僅有國內偉翔生技公司成功栽培固態子實體樟 芝。偉翔並以此技術申請栽培技術及其用途之專利4章芝的固體培養方法、 所得固體培養物及其產品與用途。本硏究原料即取自偉翔公司所生產之樟 芝子實體粉末。在偉翔之專利CN1379082A中即提其該生產方式所得之樟芝 子實體具有與一般野生樟芝一致之三帖類成分。此爲一般液態栽培所不能 達成。在用途應用方面,偉翔公司在同一專利中申請用於保肝、治療或抑 制癌細胞生長、抑制過氧化反應、抗自由基或抗脂質過氧化反應、具有皮 膚再造功能等專利。而一般民間流傳樟芝具有安神、去風行氣、活血化淤、 解毒消腫、鎭靜止痛等功能。至目前尙未發現樟芝具有促進白血球的增生 之功能·因此本發明仍利用一種萃取方法,所得到之萃取液,可提高人體 造血機能· 樟芝在化學結構鑑定方面,目前已鑑定出結構者有十七種‘α -methylergostane type新化合物,包括師大化學系程一華&gt;等人發現的antcin A、anticin B、anticin C、antcin E、antcin F、methyl antcinate'G 和 methyl antcinate H,楊書戚等人發現的 Zhankuic acid A、Zhankuic acid B、Zhankuic acid C、 Zhankuic acid D 和 Zhankuic acid E,其中 antcin A、anticin B、Zhankuic acid A 及Zhankuic acid C @別證實具有抑制老鼠血癌(P-388 murine leukemia)細胞 毒素的活性,與抗副交感神經作用(anticholinergic)及抗血清素活性 (antiserotonin);另有六種lanostane type新化合物,包括楊書戚等人發現的15 a -acetyldehydro- sulphurenic acid, dehydroeburicoic acid dehydrosulphurenic acid等三種,其中dehydroeburicoic acid已被證實則具抗炎作用,另有四種 l,3-benzodioxloe化合物,,包括姜宏哲等人找到的antrocin、 4,7-dimethoxy-5-methyl-1,3-benzodioxole 和]2,2’,5,5,-tetramethoxy -3,4,3’,4’-bimethyl enedioxy-6,6’-dimethyl- biphenyl 等。 1238852 【內容】 本發明之樟芝萃取方法係取樟芝粉末3g於40 ml H£)中,經由121°C,1 kgw/cm2壓力作用10-30分鐘後,以4000 rpm,離心10 min,取上清液分別 加入等體積之100%酒精,使其酒精最終濃度爲50%,於室溫下震盪M、時, 以4000 rpm,離心10 min,收集上清液,再以冷凍乾燥方式進行乾燥,加水 回溶成1-lOmg/ml的萃取液不同濃度的萃取液。 而經老鼠施打cyclophosphamide(癌症治療用藥劑)後,服用此一特殊製程所 萃取出之樟芝抽出物,觀察到1.對週邊血液細胞的影響,負控制組2.7000土 1.0801 X 10观,實驗組4.6250±4.2161 X ΚΡ/d,證實此一萃取物可在體內發 揮作用減緩化療對造血功能的傷害與促進白血球的增生。2.服用六天後,小 鼠骨髓細胞分離,進行colony計數實驗,colony計數實驗結果負控制組 23.7500±5.9090,正控制組 42.0000土4.9666。 此一實驗證明本創意之樟芝萃取方法所得之萃取液,實可作爲癌症的輔助 治療,以減緩因化療所引起的造血功能低下問題,促進白血球的增生。 【實施方式】 取3g樟芝粉末溶於40ml無菌水中,經由121°C,1 kgw/cm2壓力作用10-30 分鐘後,離心所得之上清液再以30-90%酒精進行萃取,離心除去沉澱物, 將上清液進行不同倍數稀釋,進行老鼠體內與體外試驗。 一、硏究材料與方法: * 1. 實驗動物:BALB/c (BALB/cByJ)小鼠,由 The Jackson Laboratory, Bar Harbor, M.E·,U.S.A.購得種鼠,在國立成功大學醫學院動物中心,以標準飼料與飲 水飼養、繁殖。實驗所採用爲鼠齡8〜12週公鼠。 2. 小鼠骨髓細胞分離:以無菌操作,取小鼠兩隻大腿骨,小心去除肌肉後, 以3mL針筒搭配27G針頭,取3mL HBSS,將骨髓細胞沖出,經離心後, 以 10mL 20%FBS 之 IMDM resuspenked,將含細胞之 IMDM medium 緩慢的 加於Ficoll solution上,經Ficoll solution以1500 rpm離心分層後,取溶液界 面之中間細胞層,_以10mL 20%FBS之IMDM resuspended,進行清洗, 1300rpm 離心後取約 106 cells/ml 於 5% FBS 之 IMDM medium(2 ng GM-CSF/per ml)中,培養於96 well plate中,經24小時後,加入樟芝萃取物,96小時 後進行MTT測試。 3· colony計數實驗:將小鼠骨髓細胞以上述方法分離後,將細胞濃度調至1〇6 cells/ml ’ 取 0.9 ml 加入 2.4 ml 之 STEMLINE™ Methylcellulose medium without Ϊ238852 growth factors,mouse(Sigma S4062),且 medium 中含 10ng/ml GM-CSF,放入 培養盤內培養7-10天,再取出計算colony的數目。 4. cyclophosphamide處理後對週邊血液細胞的影響:將BALB/c小鼠,以腹腔 注射的方式,注入cyclophosphamide 160mg/kg(SigmaC0768)的劑量,同時餵 食樟芝萃取物,觀察其週邊血液的白血球的數目是否受到影響。 5. 血樣本的收集:採血時使用已滅菌過5.75吋巴斯德細頸玻璃管,由眼窩採 血,並加入抗凝劑,約〇.2mL的血液加入含有30 ul之EDTA(72 mg/ml)的試 管內,混合均勻後以血液分類計數儀計數(ERMAparticlecounter)(PC608, ERMA Inc.,Tokyo, Japan),得到血液中白血球的量。 6. 樟芝萃取方法:取樟芝粉末3g於40 ml H£)中,經高溫高壓滅菌後,以4000 rpm,離心10 min,取上清液分別加入等體積之100%酒精,使其酒精最終 濃度爲50%於室溫下震盪8小時,以4000 rpm,離心10 min,收集上清液, 再以冷凍乾燥方式進行乾燥,加水回溶成不同濃度的萃取液。 7. 試驗物質投予途徑:每日以l.OmL無菌塑膠針筒套上不鏽鋼餵食針,管灌 餵食0.2〜0.4 mL,控制組以ΗΌ進行灌食,實驗組以樟芝進行灌食。不鏽 鋼餵食針平時浸泡在95%酒精中,使用前再以H2〇潤濕。 8. 生物統計分析:實驗結果以平均値士標準偏差來表示,並使用SigmaPlot軟 體進行圖表繪製,並以Student T test進行測定控制組與實驗組是否達到生 物統計上的顯著差異。如;7値小於〇.〇5,則代表有顯著差異。 二、實驗設計 1·樟芝水抽液以不同酒精濃度進行沉澱後之上清液溶液進行體外試驗 取3 g樟芝粉末溶於40ml之酒精或水溶液中,高溫高壓萃取後,分別 以30%、50%、75%、90%的酒精進行沉澱,分別乾燥後,將其濃度皆 調爲0.25g樟芝粉末來源之萃取物μ h2〇,將上清液溶液(表一)(圖一) 與分別加入細胞中。發現在50%的酒精萃取上清液中具有最高的促進 骨髓增生效果。 ♦ 1238852 表一、樟芝水抽液以不同酒精濃度進行沉澱後之上清液溶液進行骨髓增生ΜΤΤ 試驗結果 稀釋W00X 稀釋500Χ 稀釋mox 稀釋50X 稀釋5X 樟芝水萃取液 0.8363±0.1242 ρ=0.334 0.9203±0.1046 ρ&lt;0.05 1.0247±0.1421 p&lt;0.05 1.1390±0.1811 p&lt;0.05 90%酒精上清液 0.8730+0.0507 ρ&lt;0·05 0.9240±0.0695 p&lt;0.05 0.9987±0.0747 p&lt;0.05 0.5933+0.0539 p&lt;0.05 75%酒精上清液 0.9733±0.0570 ρ&lt;0.05 0.9583±0.0566 p&lt;0.05 0.9690±0.0185 ρ&lt;0·05 1.0650±0.0811 p&lt;0.05 50%酒精上清液 U290±0.0724 p&lt;0.05 1.2297±0.0795 p&lt;0.05 1.5377±0.0573 p&lt;0.05 30%酒精上清液 0.9300±0.1029 p&lt;0.05 1.0540±0.0405 p&lt;0.05 1.1517+0.1157 p&lt;0.05 0.9123±0.1181 p=0.060[Technical field to which the invention belongs] Cancer adjuvant therapy, medicinal fungi, functional health foods, etc., blood cell proliferation. [Previous technology] Antrodia cinnamomea is a species unique to Taiwan, so no research report on antrodia camphorata has been found in other countries around the world. In terms of solid fruiting body cultivation, many domestic fungal cultivation experts have attempted solid state cultivation of Antrodia camphorata fruit without success; currently only the domestic Weixiang Biotech Company successfully cultivates solid fruiting body Antrodia camphorata. Weixiang also applied for this technology to patent the solid culture method of Chapter 4 of the cultivation technology and its use, the obtained solid culture, and its products and uses. This research raw material is obtained from the powder of Antrodia camphorata fruit produced by Weixiang Company. In Weixiang's patent CN1379082A, it is mentioned that the Antrodia camphorata fruiting body obtained by this production method has three kinds of ingredients consistent with that of wild Antrodia camphorata. This cannot be achieved by general liquid cultivation. In terms of applications, Weixiang applied for patents for liver protection, treatment or inhibition of cancer cell growth, inhibition of peroxidation, anti-free radical or anti-lipid peroxidation, and skin reconstruction functions in the same patent. Antrodia angustifolia is generally circulated with functions such as calming the nerves, removing qi and qi, promoting blood circulation and removing stasis, detoxification and swelling, and restless pain. So far, it has not been found that Antrodia camphorata has the function of promoting the proliferation of white blood cells. Therefore, the present invention still uses an extraction method. The obtained extract can improve the human hematopoietic function. Antrodia camphorata has identified the structure of the chemical structure. There are 17 new 'α-methylergostane type compounds, including antcin A, anticin B, anticin C, antcin E, antcin F, methyl antcinate'G and methyl antcinate H, discovered by Cheng Yihua, et al., Of the Department of Chemistry of Normal University. Yang Shu Zhankuic acid A, Zhankuic acid B, Zhankuic acid C, Zhankuic acid D, and Zhankuic acid E discovered by Qi et al. Among them, antcin A, anticin B, Zhankuic acid A, and Zhankuic acid C murine leukemia) cytotoxin activity, anticholinergic and antiserotonin activity; six new lanostane type compounds, including 15 a -acetyldehydro- sulphurenic acid found by Yang Shuqi et al., dehydroeburicoic acid dehydrosulphurenic acid and other three, of which dehydroeburicoic acid has been proven to be resistant Inflammatory effects, there are four other l, 3-benzodioxloe compounds, including antrocin, 4,7-dimethoxy-5-methyl-1,3-benzodioxole and [2,2 ', 5,5,- tetramethoxy -3,4,3 ', 4'-bimethyl enedioxy-6,6'-dimethyl-biphenyl and the like. 1238852 [Content] The extraction method of Antrodia camphorata in the present invention is to take 3g Antrodia camphorata powder in 40 ml H £), apply 121 kg at 1 kgw / cm2 for 10-30 minutes at 121 ° C, and centrifuge at 4000 rpm for 10 min. Take the supernatant and add an equal volume of 100% alcohol, so that the final alcohol concentration is 50%, shake at room temperature for 10 hours, centrifuge at 4000 rpm for 10 min, collect the supernatant, and then freeze-dry Dry and add water to reconstitute the extracts with different concentrations of 1-10 mg / ml. And after cyclophosphamide (cancer treatment agent) was administered to mice, the extract of Antrodia camphorata extracted by this special process was taken, and the effect on peripheral blood cells was observed. 1. Negative control group 2.7000 soil 1.0801 X 10 view, experiment Group 4.6250 ± 4.2161 X KP / d. It was confirmed that this extract can play a role in the body to slow the damage of hematopoietic function by chemotherapy and promote the proliferation of white blood cells. 2. Six days after the administration, the bone marrow cells of the mice were separated and subjected to a colony counting experiment. The results of the colony counting experiment were negative in the control group 23.7500 ± 5.9090 and positive control group 42.0000 ± 4.9666. This experiment proves that the extract obtained from the original Antrodia camphorata extraction method can be used as an adjuvant treatment for cancer, in order to slow down the problem of hematopoietic function caused by chemotherapy, and promote the proliferation of white blood cells. [Embodiment] 3 g of Antrodia camphorata powder was dissolved in 40 ml of sterile water, and the pressure was applied at 121 ° C and 1 kgw / cm2 for 10-30 minutes. The supernatant was centrifuged and then extracted with 30-90% alcohol and removed by centrifugation. Precipitate, and the supernatant was diluted at different times for in vivo and in vitro experiments in mice. I. Research materials and methods: * 1. Experimental animals: BALB / c (BALB / cByJ) mice, which were purchased from The Jackson Laboratory, Bar Harbor, ME ·, USA, and were obtained from the Animal Center of National Cheng Kung University School of Medicine Feed and breed with standard feed and drinking water. The experiment used male rats aged 8-12 weeks. 2. Isolation of mouse bone marrow cells: Aseptically, take the two thigh bones of the mouse, carefully remove the muscles, use a 3mL syringe with a 27G needle, take 3mL of HBSS, rinse the bone marrow cells, and centrifuge to 10mL 20 % FBS IMDM resuspenked, slowly add IMDM medium containing cells to the Ficoll solution, centrifuge and layer the Ficoll solution at 1500 rpm, take the middle cell layer at the solution interface, and resuspend with 10 mL 20% FBS IMDM After washing, centrifugation at 1300 rpm, take about 106 cells / ml in IMDM medium (2 ng GM-CSF / per ml) with 5% FBS, and culture in 96 well plate. After 24 hours, add Antrodia camphorata extract for 96 hours. After the MTT test. 3. Colony counting experiment: After isolating mouse bone marrow cells in the above method, adjust the cell concentration to 10 cells / ml. Take 0.9 ml and add 2.4 ml of STEMLINE ™ Methylcellulose medium without Ϊ238852 growth factors, mouse (Sigma S4062) , And the medium contains 10ng / ml GM-CSF, put it in a culture plate for 7-10 days, and then take it out to calculate the number of colony. 4. Effect of cyclophosphamide treatment on peripheral blood cells: BALB / c mice were injected intraperitoneally with a dose of cyclophosphamide 160mg / kg (SigmaC0768), while Antrodia camphorata extract was fed, and the white blood cells of peripheral blood were observed. Whether the number is affected. 5. Collection of blood samples: 5.75-inch pasteur narrow-necked glass tubes that have been sterilized are used for blood collection. Blood is collected from the eye socket and anticoagulant is added. About 0.2 mL of blood is added to 30 ul of EDTA (72 mg / ml). In a test tube of), the mixture was evenly counted with a blood sorting counter (ERMA particle counter) (PC608, ERMA Inc., Tokyo, Japan) to obtain the amount of white blood cells in the blood. 6. Antrodia cinnamomea extraction method: take 3g antrodia cinnamomea powder in 40 ml H £), sterilize at high temperature and autoclave, centrifuge at 4000 rpm for 10 min, add the supernatant and add equal volume of 100% alcohol to make alcohol The final concentration is 50%, shaking at room temperature for 8 hours, centrifuging at 4000 rpm for 10 min, collecting the supernatant, drying it by freeze-drying, and reconstituting it with water to obtain extracts with different concentrations. 7. Test substance administration route: a stainless steel feeding needle was put on a 1.0 mL sterile plastic syringe daily, and 0.2-0.4 mL was fed by tube irrigation. The control group was fed with gadolinium and the experimental group was fed with Antrodia camphorata. Stainless steel feeding needles are usually immersed in 95% alcohol, and then wet with H2O before use. 8. Biostatistical analysis: The experimental results are expressed by the mean standard deviation of the mean, and the SigmaPlot software is used to draw the chart, and the Student T test is used to determine whether the control group and the experimental group have reached a significant difference in biostatistics. For example, 7 値 is less than 0.05, which represents a significant difference. 2. Experimental Design 1. Water extract from Antrodia camphorata was precipitated with different alcohol concentrations. The supernatant solution was tested in vitro. 3 g of Antrodia camphorata powder was dissolved in 40ml of alcohol or aqueous solution. After high temperature and high pressure extraction, 30% , 50%, 75%, and 90% alcohol were precipitated. After drying, the concentrations were adjusted to 0.25 g of an extract of Antrodia camphorata powder source μ h20, and the supernatant solution (Table 1) (Figure 1) And added to the cells separately. It was found to have the highest myeloproliferative effect in the 50% alcohol-extracted supernatant. ♦ 1238852 Table I. Antrodia camphorata water pumped and precipitated at different alcohol concentrations. The supernatant solution was subjected to bone marrow hyperplasia MTT test results. Dilution W00X dilution 500 × dilution mox dilution 50X dilution 5X Antrodia camphorata water extract 0.8363 ± 0.1242 ρ = 0.334 0.9203 ± 0.1046 ρ &lt; 0.05 1.0247 ± 0.1421 p &lt; 0.05 1.1390 ± 0.1811 p &lt; 0.05 90% alcohol supernatant 0.8730 + 0.0507 ρ &lt; 0.05 0.05 240 + 0.0695 p &lt; 0.05 0.9987 ± 0.0747 p &lt; 0.05 0.5933 + 0.0539 p &lt; 0.05 75 % Ethanol supernatant 0.9733 ± 0.0570 ρ &lt; 0.05 0.9583 ± 0.0566 p &lt; 0.05 0.9690 ± 0.0185 ρ &lt; 0.05 05 1.0650 ± 0.0811 p &lt; 0.05 50% alcohol supernatant U290 ± 0.0724 p &lt; 0.05 1.2297 ± 0.0795 p &lt; 0.05 1.5377 ± 0.0573 p &lt; 0.05 30% alcohol supernatant 0.9300 ± 0.1029 p &lt; 0.05 1.0540 ± 0.0405 p &lt; 0.05 1.1517 + 0.1157 p &lt; 0.05 0.9123 ± 0.1181 p = 0.060

Positive control(2ng/well) : 1.0940±0.0585 Negative control · 0.7698±0.0290 &lt;note&gt; p 値爲與 Negative control 比較 2·施打免疫抑制劑及餵食樟芝之小鼠外週血球數變化: 分爲3組,每組四隻,分別爲控制組、負對照組、實驗組。負對照 組與實驗組在第0天施打cyclophosphamide,160 mg/kg,實驗組並同 時餵食樟芝抽出物,負對照組餵食無菌水,持續至實驗結束,第0、 3、5、7天眼窩採血,並測外週血之白血球數f。在有施打 cyclophosphamide免疫抑制劑後,不論是否有餵食樟芝抽出物,皆在 第5天時白血球數降至最低,但有餵食樟芝抽出物的實驗組,在第3 天及第5天時、白血球數明顯較負對照組多(表二)(圖二),顯示在餵 食樟芝水抽物後,老鼠受到免疫抑制劑對白血球的破壞程度,因樟 芝水抽物而有減緩的現象。, 表二、打免疫抑制劑及餵食樟芝之小鼠外週血球數變化 第ok 第3天 第5天 第7天 控制組 5.5000+0.5568 5.4333±1.0504 7.4333±2.5502 7·7000±0·9539 負對照組(水) 5.866711.9399 2.700011.0801 0.950010.3786 9.5333±5.6766 實驗組(樟芝) 6.7333±2.9263 4.6250±4.2161 1.1500+0.3697 24.0250+35.4014 1238852 3.小鼠骨髓細胞增生體外colony培養實驗: 分爲3組,分別爲控制組、負對照組、實驗組。負對照組與實驗組 在第0天施打cyclophosphamide,160 mg/kg,實驗組並同時餵食樟芝 抽出物,負對照組餵食無菌水,連續餵食六天之後,犧牲取大腿骨 之骨髓細胞,進行colony計數實驗,實驗結果顯示樟芝水抽物餵食 對於colony的數量,相較於爲食無菌水的colony的數量高,顯示在 施打cyclophosphamide後,餓食一段時間樟芝水抽物後,對於骨髓細 胞中造血細胞數目的維持有所幫助。 表三、取BALB/c雄鼠之大腿骨之骨髓細朐淮行1〇天的培養後,計算出聚落的量 控制組(normal) 負控制組(餵食水) 實驗組(餵食樟芝) Colony 數 33.OOOOt9.8995 23.7500±5.9090 42.0000±4.9666 &lt;n〇te&gt;A控制組(餵食水)與實驗組(餵食樟芝)之p=〇.〇〇3 經由±述5@實驗設計,皆證實了樟芝粉末經由特定的萃取方式抽取之 後’不論體內或體外試驗,皆可有效的保護Cyclophosphamide化療所弓胞的造 血功能低下並促進白血球細胞的增生 【圖式簡單說明】 、 圖一 ' 棒芝:水抽液以不同酒精濃度進行沉激後之上清&amp;溶液進行骨髓增生 MTT試驗結果 圖二、打免疫抑制劑及餵食樟芝萃取液之小鼠外周血球數變化Positive control (2ng / well): 1.0940 ± 0.0585 Negative control · 0.7698 ± 0.0290 &lt; note &gt; p 値 is compared with Negative control 2 · Changes in peripheral blood cells of mice treated with immunosuppressant and Antrodia cinnamomea: divided into: Three groups, four in each group, were the control group, the negative control group, and the experimental group. The negative control group and the experimental group were treated with cyclophosphamide, 160 mg / kg on day 0. The experimental group was fed with Antrodia camphorata extract at the same time. The negative control group was fed with sterile water until the end of the experiment. Days 0, 3, 5, and 7 Blood was collected from the eye socket, and the number of white blood cells f in the peripheral blood was measured. After the administration of cyclophosphamide immunosuppressant, the white blood cell count was reduced to the minimum on day 5 regardless of whether the Antrodia camphorata extract was fed, but the experimental group with the Antrodia camphorata extract on the 3rd and 5th day Compared with the negative control group, the number of white blood cells was significantly higher than that of the negative control group (Table 2) (Figure 2). phenomenon. Table 2. Changes in the number of peripheral blood cells in mice that were immunosuppressed and fed with Antrodia camphorata. Day 3 Day 5 Day 7 Control group 5.5000 + 0.5568 5.4333 ± 1.0504 7.4333 ± 2.5502 7.7000 ± 0 · 9539 negative Control group (water) 5.866711.9399 2.700011.0801 0.950010.3786 9.5333 ± 5.6766 Experimental group (Antrodia) 6.7333 ± 2.9263 4.6250 ± 4.2161 1.1500 + 0.3697 24.0250 + 35.4014 1238852 3. Mouse bone marrow cell proliferation in vitro colony culture experiment: divided into Three groups, namely the control group, the negative control group, and the experimental group. The negative control group and the experimental group were treated with cyclophosphamide, 160 mg / kg on day 0. The experimental group was fed with Antrodia extract at the same time. The negative control group was fed with sterile water. After six consecutive days of feeding, the bone marrow cells of the femur were sacrificed. A colony counting experiment was performed. The experimental results showed that the quantity of colony fed with Antrodia camphorata water extract was higher than that of colony fed sterile water. It is helpful for maintaining the number of hematopoietic cells in bone marrow cells. Table 3. After 10 days of culturing the bone marrow of the thigh bone of male BALB / c male rats, the amount of colony was calculated. Normal control group (feeding water) Experimental group (feeding Antrodia camphorata) Colony Number 33.OOOOt9.8995 23.7500 ± 5.9090 42.0000 ± 4.9666 &lt; n〇te &gt; A control group (feeding water) and experimental group (feeding Antrodia camphorata) p = 0.03. It was confirmed that Antrodia camphorata powder was extracted through a specific extraction method, 'no matter in vivo or in vitro tests, it can effectively protect the toxocytosis of Cyclophosphamide chemotherapy cells and promote the proliferation of white blood cells. [Schematic description], Figure 1' Zhi: water-extracted liquid with different concentrations of alcohol after being stimulated with supernatant &amp; solution for bone marrow hyperplasia MTT test results

Claims (1)

1238852 申請專利範圍 1. 一種可提高人體造血機能的樟芝萃取物之製備方法, 將樟芝粉末3g於40 ml水中,經由121°C,1 kgw/cm2壓力作用1〇_3〇 分鐘後,以40⑻rpm,離心10 min,取上清液分別加入等體積之100% 酒精,使其酒精最終濃度爲50%,於室溫下震盪8小時,以4000 rpm, 離心10 min,收集上清液,再以冷凍乾燥方式進行乾燥’加水回裕 成不同濃度l-10mg/ml的萃取液。1238852 Scope of patent application 1. A method for preparing antrodia cinnamomea extract which can improve human hematopoietic function. 3g of antrodia camphorata powder in 40 ml of water is applied at 121 ° C and 1 kgw / cm2 pressure for 10-30 minutes. Centrifuge at 40⑻rpm for 10 min, add equal volume of 100% alcohol to make the final alcohol concentration of 50%, shake at room temperature for 8 hours, and centrifuge at 4000 rpm for 10 min to collect the supernatant. Then freeze-dry it and dry it. Add water to make it into an extract with different concentration of l-10mg / ml.
TW92124881A 2003-09-09 2003-09-09 A new extraction method and application of antrodia camphorata to reduce the damage from chemotherapy for cancer and enhance the erythropoiesis in bone marrow TWI238852B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW92124881A TWI238852B (en) 2003-09-09 2003-09-09 A new extraction method and application of antrodia camphorata to reduce the damage from chemotherapy for cancer and enhance the erythropoiesis in bone marrow

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW92124881A TWI238852B (en) 2003-09-09 2003-09-09 A new extraction method and application of antrodia camphorata to reduce the damage from chemotherapy for cancer and enhance the erythropoiesis in bone marrow

Publications (2)

Publication Number Publication Date
TW200510523A TW200510523A (en) 2005-03-16
TWI238852B true TWI238852B (en) 2005-09-01

Family

ID=37001120

Family Applications (1)

Application Number Title Priority Date Filing Date
TW92124881A TWI238852B (en) 2003-09-09 2003-09-09 A new extraction method and application of antrodia camphorata to reduce the damage from chemotherapy for cancer and enhance the erythropoiesis in bone marrow

Country Status (1)

Country Link
TW (1) TWI238852B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104273540A (en) * 2014-10-20 2015-01-14 中山安荞生物科技有限公司 Antrodia camphorata composition
TWI586359B (en) * 2015-08-27 2017-06-11 喬本生醫股份有限公司 Use of extract composition of fruiting body of antrodia cinnamomea

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI601535B (en) * 2016-06-23 2017-10-11 台灣利得生物科技股份有限公司 Composition of Astragalus membranaceus L. and fruit solid culture mycelium water and ethanol extract for application of anticancer drug adjuvant
CN107536854A (en) * 2016-06-23 2018-01-05 台湾利得生物科技股份有限公司 Antrodia camphorata active composition with chemotherapeutic drug adjuvant effect and application thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104273540A (en) * 2014-10-20 2015-01-14 中山安荞生物科技有限公司 Antrodia camphorata composition
TWI586359B (en) * 2015-08-27 2017-06-11 喬本生醫股份有限公司 Use of extract composition of fruiting body of antrodia cinnamomea

Also Published As

Publication number Publication date
TW200510523A (en) 2005-03-16

Similar Documents

Publication Publication Date Title
CN1207005C (en) Rabbit skin containing bioactive substance and its use
CN105477017A (en) Mixed stem cell preparation for treating diabetic foot and preparation method of mixed stem cell preparation
CN101690811B (en) Concentrated freeze-dried yolk antibody composite preparation for infectious bursal disease and preparation process thereof
CN104783182B (en) A kind of composition for improving immunity and preparation method thereof
TW201618801A (en) Pharmaceutical composition for adjuvant chemotherapy drugs and use thereof
TWI238852B (en) A new extraction method and application of antrodia camphorata to reduce the damage from chemotherapy for cancer and enhance the erythropoiesis in bone marrow
CN1301666C (en) Health food capable of raising immunity and its production process
CN107551095B (en) A skin repairing agent for psoriasis prepared from stem cell extract and Chinese medicinal extract
CN102727581A (en) Pharmaceutical composition with wound repairing effect
CN101574388A (en) Cordyceps oral solution and preparation method thereof
CN113621042B (en) Method for inducing negative oxygen ions by living organisms and application thereof, negative oxygen ion coating, far infrared negative oxygen ion powder and preparation method
CN110354247B (en) Haematococin compound preparation for treating oral candidiasis and preparation method thereof
CN1327047A (en) Method for cultivating variotin pecilocin with silkworm and medicinal use
CN113797248A (en) Stem cell preparation for activating hair follicle regeneration
CN101647567B (en) Ganoderma lucidum liquid preparation and preparation method thereof
CN106540246B (en) Fibroblast vaccine and preparation method and application thereof
CN1127948C (en) Microencapsulated bovine adrenal medulla chromaffin cell-drug for alleviating pain
CN120514659A (en) Medical gel for repairing skin damage and its application
CN1298379C (en) Medicine for curing malignant tumors of carcinoma of prostate, liver cancer and sarcoma
CN111714520A (en) Periplaneta americana preparation and preparation method and application thereof
CN120330139B (en) A method for culturing mesenchymal stem cells and its application in treating leukemia
CN110917287A (en) A medicinal plant extract
CN113663052B (en) Pharmaceutical composition for treating brain glioma and preparation method thereof
CN104825574A (en) Sleep improving composition and preparation method thereof
CN121197244A (en) A Chinese herbal composition of Cordyceps militaris and its preparation method and application

Legal Events

Date Code Title Description
MK4A Expiration of patent term of an invention patent